Please use this identifier to cite or link to this item:
Title: Severe scalp hair loss in a female patient with acromegaly treated with lanreotide autogel after unsuccessful surgery.
Issue Date: Nov-2015
Citation: Clin Case Rep.2015 Nov;(3)11:945-8
Abstract: Scalp hair loss is an underreported adverse event of somatostatin analogs therapy that in severe cases may require treatment withdrawal. It can be related to an acute decrease in GH/IGF-1 levels, but a direct effect cannot be ruled out.
PMID: 26576278
Rights: openAccess
ISSN: 2050-0904
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos
Hospitales > H. U. La Paz > Artículos

Files in This Item:
File Description SizeFormat 
PMC4641480.pdf607.9 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.